1. Home
  2. PFLT vs ABCL Comparison

PFLT vs ABCL Comparison

Compare PFLT & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFLT
  • ABCL
  • Stock Information
  • Founded
  • PFLT 2010
  • ABCL 2012
  • Country
  • PFLT United States
  • ABCL Canada
  • Employees
  • PFLT N/A
  • ABCL N/A
  • Industry
  • PFLT Finance: Consumer Services
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFLT Finance
  • ABCL Health Care
  • Exchange
  • PFLT Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • PFLT 924.7M
  • ABCL 818.2M
  • IPO Year
  • PFLT N/A
  • ABCL 2020
  • Fundamental
  • Price
  • PFLT $11.28
  • ABCL $2.31
  • Analyst Decision
  • PFLT Strong Buy
  • ABCL Buy
  • Analyst Count
  • PFLT 2
  • ABCL 3
  • Target Price
  • PFLT $12.00
  • ABCL $7.00
  • AVG Volume (30 Days)
  • PFLT 1.3M
  • ABCL 3.9M
  • Earning Date
  • PFLT 05-07-2025
  • ABCL 05-06-2025
  • Dividend Yield
  • PFLT 10.90%
  • ABCL N/A
  • EPS Growth
  • PFLT 16.92
  • ABCL N/A
  • EPS
  • PFLT 1.37
  • ABCL N/A
  • Revenue
  • PFLT $215,391,000.00
  • ABCL $28,833,000.00
  • Revenue This Year
  • PFLT $48.14
  • ABCL $37.12
  • Revenue Next Year
  • PFLT $9.03
  • ABCL $41.98
  • P/E Ratio
  • PFLT $8.25
  • ABCL N/A
  • Revenue Growth
  • PFLT 47.56
  • ABCL N/A
  • 52 Week Low
  • PFLT $10.28
  • ABCL $2.11
  • 52 Week High
  • PFLT $12.02
  • ABCL $4.75
  • Technical
  • Relative Strength Index (RSI)
  • PFLT 54.32
  • ABCL 39.31
  • Support Level
  • PFLT $10.85
  • ABCL $2.32
  • Resistance Level
  • PFLT $11.46
  • ABCL $2.60
  • Average True Range (ATR)
  • PFLT 0.13
  • ABCL 0.13
  • MACD
  • PFLT 0.03
  • ABCL 0.02
  • Stochastic Oscillator
  • PFLT 69.67
  • ABCL 40.82

About PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: